BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/21/2024 7:25:52 AM | Browse: 55 | Download: 160
 |
Received |
|
2024-01-03 02:37 |
|
Peer-Review Started |
|
2024-01-03 02:38 |
|
First Decision by Editorial Office Director |
|
2024-03-09 03:15 |
|
Return for Revision |
|
2024-03-09 09:33 |
|
Revised |
|
2024-03-20 01:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-17 02:30 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-17 07:57 |
|
Articles in Press |
|
2024-04-17 07:57 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-09 00:33 |
|
Publish the Manuscript Online |
|
2024-05-21 07:25 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Receptor tyrosine kinase-like orphan receptor 1: A novel antitumor target in gastrointestinal cancers
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zheng-Long Wu, Ying Wang, Xiao-Yuan Jia, Yi-Gang Wang and Wang Hui |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Hangzhou Medical Health Science and Technology Project |
B20220173 |
| the Public Welfare Technology Project of Zhejiang Province |
LGF21H160033 |
| Zhejiang Medical Technology Plan Project |
2021KY047 |
|
| Corresponding Author |
Yi-Gang Wang, PhD, Associate Professor, Professor, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, No. 2 Street of Xiasha District, Hangzhou 310018, Zhejiang Province, China. ygwang@zstu.edu.cn |
| Key Words |
ROR1; Gastrointestinal cancers; Therapeutic target; Molecular mechanisms; Antitumor strategies |
| Core Tip |
Delve into a comprehensive review spotlighting receptor tyrosine kinase-like orphan receptor 1 (ROR1) pivotal involvement in gastrointestinal cancer advancement and its promising prospects as an anti-tumor remedy. Explore pivotal cellular pathways governing ROR1 regulation and pertinent insights into existing commercial therapeutic offerings. Emphasizing ROR1’s crucial role in gastrointestinal cancer treatment, this review offers a nuanced blend of historical context and scientific insight, illuminating the dynamic landscape of this evolving field. |
| Publish Date |
2024-05-21 07:25 |
| Citation |
Wu ZL, Wang Y, Jia XY, Wang YG, Hui W. Receptor tyrosine kinase-like orphan receptor 1: A novel antitumor target in gastrointestinal cancers. World J Clin Oncol 2024; 15(5): 603-613 |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i5/603.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i5.603 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
